Track 1: Hepatology

Hepatology is the branch of medicine that incorporates the study of liver, gallbladder, biliary tree, and pancreas function as well as management of their disorders. The study of these organ deals with the understanding of clinical syndrome of non-cirrhotic portal hypertension and Congenital Hepatic Fibrosis; study the biological processes underlying the development of hepatic regeneration and study aspects of viral hepatitis that allow insight into disease mechanisms.

Relevant Conferences:

3^rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5^th World Congress on Virology Conference, December 07-09, 2015, USA; 2^nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5^th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31^st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016 Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA

Track 2: Diagnosing Liver Diseases

Diagnosis for Liver diseases has been advocated with the intention of intervening to halt its progression. Abnormal liver tests are those that measure synthesis of proteins made by the liver (albumin, clotting factors) or the liver's capacity to metabolize drugs. The impact of diagnosis of hepatitis C virus on quality of life is worse in patients aware of their viral status compared with individuals unaware of their viral status. Ultrasound-based transient elastography is the advanced technology more commonly used for the assessment of chronic liver diseases. It is also used to predict complications in patients with Liver cirrhosis.

Relevant Conferences:

3^rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5^th World Congress on Virology Conference, December 07-09, 2015, USA; 2^nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5^th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 2016 Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; The Liver Transplant Symposium, November 06-08, 2015, Singapore; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; International Meeting on Living Donor Liver Transplantation, September 28-29, 2015, Barcelona, Spain; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA

Track 3: HBV and HCV Vaccines

The Food and Drug Administration approved the first vaccine for hepatitis B in 1981. The currently used hepatitis B vaccines are made synthetically. The global market for hepatitis B vaccine is growing at a significant rate due to increasing number of cases with hepatitis B infection. In addition, growing population and growing awareness for improved healthcare facilities is increasing the global market for hepatitis B vaccine. North America dominates the global hepatitis B vaccines market due to increasing prevalence of hepatitis B infection cases and improved healthcare facilities in the region. In addition, government initiatives and more awareness among the people are some of the major factors driving the hepatitis B vaccines market. Asia, followed by Europe, is expected to experience high growth rate in the next few years in hepatitis B vaccines market. China and India are expected to be the fastest growing hepatitis B vaccines markets in Asian region.

Relevant Conferences:

3^rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5^th World Congress on Virology Conference, December 07-09, 2015, USA; 2^nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5^th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; European Gastroenterology Conference, October 24-26, 2016, Valencia, Spain; Pancreas and Islet Transplant Association, International Xenotransplantation Association and Cell Transplant Society, November 15-19, 2015, Melbourne, Australia; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA; French Pancreatic Club 30^th Annual Meeting, September 17-18, 2015 Toulouse, France

Track 4: Liver Diseases

Liver is responsible for many critical functions within the body. It helps your body digest food, store energy, and remove poisons. If it becomes diseased or injured, the loss of those functions can cause significant damage to the body. There are over 100 different forms of liver disease that affect men, women and children. These diseases include cirrhosis, alcohol abuse, hepatitis A, B, C, D, and E, Epstein Barr virus (infectious mononucleosis), non-alcoholic fatty liver disease and iron overload (hemochromatosis). The main symptoms of liver imbalance include weakness and fatigue, weight loss, nausea, vomiting, and yellow discoloration of the skin (jaundice).

Relevant Conferences:

3^rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5^th World Congress on Virology Conference, December 07-09, 2015, USA; 2^nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5^th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31^st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; The Liver Transplant Symposium, November 06-08, 2015, Singapore; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; International Meeting on Living Donor Liver Transplantation, September 28-29, 2015, Barcelona, Spain; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA

Track 5: Viral and Non-viral Hepatitis

Treatment of Hepatitis is on the cutting edge of medicine. Hepatitis B virus infection (HBV) has been recognized as a major health problem worldwide and Hepatitis C virus infection is the most common chronic blood borne infection in the United States. Viral hepatitis treatment depends on how active the virus is in your body. Viral hepatitis is the most common cause of hepatitis worldwide. Other causes of non-viral hepatitis include alcoholic hepatitis and autoimmune hepatitis.  

Relevant Conferences:

3^rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5^th World Congress on Virology Conference, December 07-09, 2015, USA; 2^nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5^th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; Latin and Ibero American Congress of Paediatric Gastroenterology, Hepatology and Nutrition, November 18-21, 2015, Lima, Peru; French Pancreatic Club 30^th Annual Meeting, September 17-18, 2015 Toulouse, France; Joint Congress of the International Pancreas and Islet Transplant Association, International Xenotransplantation Association and Cell Transplant Society, November 15-19, 2015, Melbourne, Australia; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA

Track 6: Hepatitis Antigens and Antibodies

Hepatitis Be antigen (HBeAg) is found in the early phase of hepatitis B infection soon after hepatitis Bs antigen becomes detectable. Serum levels of both antigens rise rapidly during the period of viral replication. The presence of HBeAg correlates with hepatitis B virus (HBV) infectivity, the number of viral Dane particles, the presence of core antigen in the nucleus of the hepatocyte, and presence of viral DNA polymerase in serum. During recovery from acute hepatitis B, after HBeAg level declines and becomes undetectable, HBe antibody (anti-HBe) appears in the serum. Anti-HBe usually remains detectable for several years after recovery from acute infection.

Relevant Conferences:

3^rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5^th World Congress on Virology Conference, December 07-09, 2015, USA; 2^nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5^th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; French Pancreatic Club 30th Annual Meeting, September 17-18, 2015 Toulouse, France; Joint Congress of the International Pancreas and Islet Transplant Association, International Xenotransplantation Association and Cell Transplant Society, November 15-19, 2015, Melbourne, Australia; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA

Track 7: Hepatocellular Carcinoma and Pancreatic Cancer           

Hepatocellular carcinoma accounts for most liver cancers. This type of liver cancer occurs more often in men than women and is usually seen in people age 50 or older. It is commonly associated with cirrhosis and hepatitis. The incidence of hepatocellular carcinoma is highest in Asia and Africa, where the endemic high prevalence of hepatitis B and hepatitis C strongly predisposes to the development of chronic liver disease and subsequent development of hepatocellular carcinoma. Other risk factors can include a history of alcohol abuse.

Relevant Conferences:

3^rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5^th World Congress on Virology Conference, December 07-09, 2015, USA; 2^nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5^th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA; 2016 Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA.

Track 8: Pancreatic and Biliary Duct Diseases

The pancreas and biliary tract is crucial secondary organ for the human digestive system as when they don't work properly, it affects the entire body. Pancreatic and biliary tract problems can cause severe abnormalities such as stomach pain, bloating, nausea and vomiting. Anyone with such symptoms, especially when they are severe and long lasting, should see a doctor immediately as to receive perfect care and prevention.

Relevant Conferences:

International Pancreatic Disorders Conference, May 12-14, 2016, USA; International Pancreatic and Colorectal Cancer Conference, March 29-30, 2016, USA; 2^nd International Hepatology Conference, May 09-11, 2016, USA; 6^th Gastroenterology and Gastroenterologists Annual Meeting, June 16-18, 2016, USA; European Gastroenterology Conference, October 24-26, 2016, Valencia, Spain; French Pancreatic Club 30^th Annual Meeting, September 17-18, 2015 Toulouse, France; Joint Congress of the International Pancreas and Islet Transplant Association, International Xenotransplantation Association and Cell Transplant Society, November 15-19, 2015, Melbourne, Australia; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA

Track 9: Transplantation and Surgery

Liver transplantation surgery technique to replace a diseased or injured liver with a healthy liver delivered from a healthy person. The liver is involved in various metabolic functioning including metabolism of drugs and toxins, removing degradation products of normal body metabolism (for example clearance of ammonia and bilirubin from the blood), and synthesis of many important proteins and enzymes (such as factors necessary for blood to clot). Doctors or surgeons suggest liver transplant surgery to the patients who suffer from severe Drug-induced liver injury (DILI) or Chronic liver failure. This surgery carries a risk of other complications including infection, liver inflammation, blood clots, liver rejection, memory and thinking problems.

Relevant Conferences:

3^rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5^th World Congress on Virology Conference, December 07-09, 2015, USA; 2^nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5^th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; National Liver Conference, September 18, 2015, Fort Worth, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; International Meeting on Living Donor Liver Transplantation, September 28-29, 2015, Barcelona, Spain; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; The Liver Transplant Symposium, November 06-08, 2015, Singapore.

Track 10: Bile formation and Related Diseases

Bile is a fluid that is made and released by the liver and stored in the gallbladder. Bile helps with digestion. It breaks down fats into fatty acids, which can be taken into the body by the digestive tract. Bile contains mostly cholesterol, bile acids and bilirubin. It also contains water, body salts, copper and other metals.

Relevant Conferences:

International Pancreatic Disorders Conference, May 12-14, 2016, USA; International Pancreatic and Colorectal Cancer Conference, March 29-30, 2016, USA; 2^nd International Hepatology Conference, May 09-11, 2016, USA; 6^th Gastroenterology and Gastroenterologists Annual Meeting, June 16-18, 2016, USA; European Gastroenterology Conference, October 24-26, 2016, Valencia, Spain; French Pancreatic Club 30th Annual Meeting, September 17-18, 2015 Toulouse, France; Joint Congress of the International Pancreas and Islet Transplant Association, International Xenotransplantation Association and Cell Transplant Society, November 15-19, 2015, Melbourne, Australia; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA

Track 11: Entrepreneurs Investment Meet

Entrepreneurs Investment Meet is a global platform aimed to connect Entrepreneurs, Proposers and the Investors worldwide. It intended to create and facilitate the most optimized and viable business meeting place for engaging people in to constructive discussions, evaluation and execution of promising business ideas. An investor could be able to find out the highest potential investment opportunities, which provide good return on investment. For entrepreneurs, this would be an ideal place to find out suitable investors and partners to start or expand their business.

Relevant Conferences:

International Pancreatic Disorders Conference, May 12-14, 2016, USA; International Pancreatic and Colorectal Cancer Conference, March 29-30, 2016, USA; 2^nd International Hepatology Conference, May 09-11, 2016, USA; 6^th Gastroenterology and Gastroenterologists Annual Meeting, June 16-18, 2016, USA; European Gastroenterology Conference, October 24-26, 2016, Valencia, Spain; Pancreas and Islet Transplant Association, International Xenotransplantation Association and Cell Transplant Society, November 15-19, 2015, Melbourne, Australia; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA; French Pancreatic Club 30^th Annual Meeting, September 17-18, 2015 Toulouse, France